Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

NCT01547741 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1871

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Docetaxel
DRUG: Paclitaxel

Sponsor

NSABP Foundation Inc

Collaborators

[object Object]